PRKN and Parkinson disease: Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop in Parkin’s pathogenesis (PARK2)-linked PD, paving the way for the exploration of its potential as a biomarker and treatment target (Mouton-Liger et al., 2018).